...where the $8,000,000 Avot investment originated(please not Lincoln and/or Swartz again!).

Also, what damages are being sought from DB by way of compensation for having the money tied-up in the recommended ARS which prevented PTSC from partaking in the Avot investment?

If the MMP Portfolio is in the process of being sold, it all becomes clear now as to why Mr Moore assigned his patents to his Trust Fund. There was nothing naive in that move whatsoever, in my very humble opinion.

I have a minimum figure in mind as to what I believe would be a fair price for PTSC's 50% undisputed ownership, which I will not disclose because there are still questions as to ownership of the remaining 50%. If it transpires the TPL only have licensing rights, I would expect a separate arrangement between them and the purchaser outwith negotiations for the porfolio.

The one valuable asset that TPL does have is the reverse-engineered processor database, the sale of which should let them make a profit too.

Yes, I too am disappointed that the MMP Portfolio wasn't the golden goose that I expected when buying into PTSC but that is not to say all hope for revenues from it are redundant.

I look forward to seeing how Avot's algorithms will be incorporated so as to make Crossflo the provider of choice when combining disparate systems in the provision of, at least, healthcare.(Crossflo may have been unwanted 8 months ago as a stand-alone, or for standardized information systems now, but it would appear that RG just may have the requisite components for something at least resembling the proverbial magic bullet).

Spinners, E&OE.

Be well